MMP9 and neoplasm: To monitor the tumor-targeted neo-peptide delivery of MMP2/MMP9-responsive Pep-4 NP, a Cy5.5-labeled Pep-4 was applied to generate NPs (Pep-4 Cy5.5 NP) as described before.